jRCT ロゴ

臨床研究等提出・公開システム

Top

Japanese

Sept. 11, 2024

Feb. 04, 2025

jRCT2022240022

Exploratory Trial of NP039 for Thoracic Aortic Replacement

Exploratory Trial of NP039 for Thoracic Aortic Replacement

Nishibata Nozomi

NIPRO CORPORATION

3023, Nojicho, Kusatsu, Shiga

+81-77-564-9467

nishibata-nozomi@nipro.co.jp

Nishibata Nozomi

NIPRO CORPORATION

3023, Nojicho, Kusatsu, Shiga

+81-77-564-9467

nishibata-nozomi@nipro.co.jp

Recruiting

Dec. 01, 2024

40

Interventional

randomized controlled trial

single blind

active control

parallel assignment

treatment purpose

-Written informed consent from patients or legal representative if patients lack of ability to consent.
-Over 18 years of age at the time of acquiring consent.
, etc.

1. emergency surgery patients
2. patients undergoing revision surgery on the same incision site
3. poorly controlled diabetic patients
4. immunocompromised patients
5. patients with severe drug allergy
,etc.

18age old over
No limit

Patients with vascular anastomoses that may not achieve hemostasis by ligation or normal surgical pr

The anastomosis will be reinforced with the investigational device NP039 or the control device by random assignment and the examinations and observations specified in the protocol will be performed.

Reinforcement success rate per case

NIPRO CORPORATION
Tohoku University Hospital Institutional Review Board
1-1 Seiryo-machi, Aoba-ku, Sendai, Miyagi, 980-8574, Japan, Miyagi

+81-22-717-7000

chiken@chiken.hosp.tohoku.ac.jp
Not approval

No

none

History of Changes

No Publication date
2 Feb. 04, 2025 (this page) Changes
1 Sept. 11, 2024 Detail